In the pre-antibiotics era, the leading cause of CSVT were the septic processes, currently the aseptic form of CSVT is the most common cause. CSVT represents almost 0.5% -3% of all the types of stroke, affecting predominantly younger people, with an estimated incidence for adults of 3-4 per million, and for children 7 per million. This work aims to review current knowledge about CSVT including its pathogenesis, etiology, clinical manifestations, diagnosis, and treatment.Ĭerebral sinus venous thrombosis (CSVT) is a rare form of venous thromboembolism (VTE). Mortality trends have diminished, and with the new technologies, surely it will continue. Correcting the cause, generally the complications can be prevented. Prognosis depends on the early detection. The symptoms may appear in relation to increased intracranial pressure imitating a pseudotumorcerebri. This disease can affect the cerebral venous drainage and related anatomical structure. Patients who presents with CSVT should underwent to CT-scan venography (CVT) and to the proper inquiry of the generating cause. CSVT is a multifactorial condition with gender-related specific causes, with a wide clinical presentation, the leading causes differ between developed and developing countries, converting CSVT in a condition characterized by a highly variable clinical spectra, difficult diagnosis, variable etiologies and prognosis that requires fine medical skills and a high suspicious index.
Cerebral sinus venous thrombosis (CSVT) is a rare phenomenon that can be seen with some frequency in young patients.